3.9 Article

Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection

Journal

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
Volume 59, Issue 2, Pages 207-220

Publisher

WILEY
DOI: 10.1111/j.1574-695X.2010.00693.x

Keywords

Pseudomonas aeruginosa; cystic fibrosis; host-pathogen interaction; pulmonary infection

Funding

  1. National Science and Engineering Research Council (NSERC)
  2. Northern Ontario School of Medicine (NOSM)
  3. Ontario Graduate Scholarship
  4. Lakehead University

Ask authors/readers for more resources

Pseudomonas aeruginosa is the major cause of chronic pulmonary disease in cystic fibrosis (CF) patients. During chronic infection, P. aeruginosa lose certain virulence factors, transform into a mucoid phenotype, and develop antibiotic resistance. We hypothesized that these genetic and phenotypic alterations of P. aeruginosa affect the airway epithelial responses. A549 cells were infected with 27 well-characterized isolates of P. aeruginosa from CF patients obtained during longitudinal observation, or with P. aeruginosa mutant strains lacking flagella, pili, lipopolysaccharide, or pyocyanin. Pseudomonas aeruginosa isolates from the early stages of the infection exhibited high adherence to A549 cells, were readily internalized, and able to induce reactive oxygen species (ROS) production, apoptosis of infected cells, and the release of granulocyte macrophage colony-stimulating factor. Late P. aeruginosa isolates collected from patients with chronic lung infection were shown to have reduced adherence to and internalization into A549 cells compared with bacteria from patients with intermittent P. aeruginosa colonization, and induced lower production of ROS and apoptosis, but caused high proinflammatory cytokine and adhesion molecule expression. Our findings suggest that despite the loss of virulence factors during the adaptation process in the CF lung by late P. aeruginosa strains, they retain high proinflammatory abilities that likely contribute to the disease pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model

Kim Thomsen, Lars Christophersen, Christian Johann Lerche, Dennis Back Holmgaard, Henrik Calum, Niels Hoiby, Claus Moser

Summary: The combination of azithromycin and anti-Pseudomonas IgY therapy enhances bacterial killing and pulmonary elimination of P. aeruginosa, leading to a decrease in inflammatory markers and potential clinical application for improving anti-Pseudomonas strategies.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Article Pediatrics

Maintaining normal lung function in children with cystic fibrosis is possible with aggressive treatment regardless of Pseudomonas aeruginosa infections

Christine Ronne Hansen, Marita Gilljam, Hanne V. Olesen, Niels Hoiby, Ferenc Karpati, Ewa Johansson, Christina Krantz, Marianne Skov, Tacjana Pressler, Anders Lindblad

ACTA PAEDIATRICA (2021)

Review Microbiology

Tolerance and resistance of microbial biofilms

Oana Ciofu, Claus Moser, Peter Ostrup Jensen, Niels Hoiby

Summary: Chronic infections caused by microbial biofilms pose a significant clinical challenge due to the resistance of biofilms to antimicrobials and the immune system, leading to persistent and recurrent infections. This Review discusses the current understanding of the mechanisms underlying the tolerance of biofilms to the immune system and to antimicrobials, as well as their role in the development of antimicrobial resistance.

NATURE REVIEWS MICROBIOLOGY (2022)

Article Infectious Diseases

Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine wounds

Anne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, Niels Hoiby, John Sigurd Mjoen Svendsen, Wenche Stensen, Kim Thomsen, Jorunn Pauline Cavanagh, Claus Moser

Summary: This study aimed to investigate whether adjunctive AMC-109 could augment the ciprofloxacin effect in a chronic Pseudomonas aeruginosa wound model. The results showed that the combined treatment group had a lower bacterial load, decreased pro-inflammatory response, and improved tissue remodeling.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2022)

Article Immunology

Dynamics of a Staphylococcus aureus infective endocarditis simulation model

Franziska A. Schwartz, Luna Nielsen, Struve Jessica Andersen, Magnus Bock, Lars Christophersen, Torgny Sunnerhagen, Christian Johann Lerche, Lene Bay, Henning Bundgaard, Niels Hoiby, Claus Moser

Summary: This study aimed to further characterize the time course of biofilm formation and the impact on antibiotic tolerance development. The findings indicate that both a Staphylococcus aureus reference strain and three clinical IE isolates formed biofilms on the IEV after 6 hours.

APMIS (2022)

Article Ecology

Polymicrobial infections can select against Pseudomonas aeruginosa mutators because of quorum-sensing trade-offs

Adela M. Lujan, Steve Paterson, Elze Hesse, Lea M. Sommer, Rasmus L. Marvig, M. D. Sharma, Ellinor O. Alseth, Oana Ciofu, Andrea M. Smania, Soren Molin, Helle Krogh Johansen, Angus Buckling

Summary: Co-infecting pathogens can influence the selection of Pseudomonas aeruginosa mutators, limiting their fixation. This study is important for understanding bacterial evolution in chronic infections.

NATURE ECOLOGY & EVOLUTION (2022)

Article Immunology

Effects of antibiotic treatment and phagocyte infiltration on development of Pseudomonas aeruginosa biofilm-Insights from the application of a novel PF hydrogel model in vitro and in vivo

Hong Wu, Lulu Song, Joey Kuok Hoong Yam, Marian Plotkin, Hengzhuang Wang, Morten Rybtke, Dror Seliktar, Theodoros Kofidis, Niels Hoiby, Tim Tolker-Nielsen, Zhijun Song, Michael Givskov

Summary: The study investigated the development and study of Pseudomonas aeruginosa biofilms using PF hydrogel material in vitro and in vivo. The results showed that the biofilms formed typical structures in the PF hydrogel and were tolerant to antibiotics and host immune response. The PF hydrogel biofilm model is simple and has various applications.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Microbiology

Chicken IgY reduces the risk of Pseudomonas aeruginosa urinary tract infections in a murine model

Franziska A. Schwartz, Lars Christophersen, Kim Thomsen, Sarah Baekdal, Maria Pals Bendixen, Mette Jorgensen, Ida Kirstine Bull Rasmussen, Anne Sofie Laulund, Niels Hoiby, Claus Moser

Summary: Passive intravesical administration of avian egg yolk anti-Pseudomonas antibodies (IgY) may be a novel strategy to prevent urinary tract infections with Pseudomonas aeruginosa.

FRONTIERS IN MICROBIOLOGY (2022)

Article Microbiology

Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms

Eva Armengol, Kasper Norskov Kragh, Tim Tolker-Nielsen, Josep M. Sierra, Doaa Higazy, Oana Ciofu, Miguel Vinas, Niels Hoiby

Summary: The combination of colistin and rifampicin has been found to effectively kill colistin-resistant Pseudomonas aeruginosa, suggesting it as a promising treatment for infections caused by this strain.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Immunology

Attainment of Target Antibiotic Levels by Oral Treatment of Left-sided Infective Endocarditis: A POET Substudy

Magnus Bock, Anna Marie Theut, Johan G. C. van Hasselt, Hengzhuang Wang, Kurt Fuursted, Niels Hoiby, Christian Johann Lerche, Nikolaj Ihlemann, Sabine Gill, Ulrik Christiansen, Hans Linde Nielsen, Lars Lemming, Hanne Elming, Jonas A. Povlsen, Niels Eske Bruun, Dan Hofsten, Emil L. Fosbol, Lars Kober, Martin Schultz, Mia M. Pries-Heje, Jonas Henrik Kristensen, Jens Jorgen Christensen, Flemming S. Rosenvinge, Christian Torp Pedersen, Jannik Helweg-Larsen, Niels Tonder, Kasper Iversen, Henning Bundgaard, Claus Moser

Summary: Pharmacokinetic/pharmacodynamic analyses were conducted to assess the probabilities of target attainment for oral treatments of infective endocarditis. The majority of patients achieved the target level with orally administered antibiotics, supporting the efficacy of oral step-down antibiotic treatment in patients with infective endocarditis.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis

Magnus Bock, Johan G. C. Van Hasselt, Franziska Schwartz, Hengzhuang Wang, Niels Hoiby, Kurt Fuursted, Nikolaj Ihlemann, Sabine Gill, Ulrik Christiansen, Niels Eske Bruun, Hanne Elming, Jonas A. Povlsen, Lars Kober, Dan E. Hofsten, Emil L. Fosbol, Mia M. Pries-Heje, Jens Jorgen Christensen, Flemming S. Rosenvinge, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tonder, Kasper Iversen, Henning Bundgaard, Claus Moser

Summary: This study characterized the population pharmacokinetics of linezolid in patients with infective endocarditis and found that there is a substantial interaction between linezolid and rifampicin, which increases the clearance of linezolid. Model-based simulations showed that increasing the linezolid dose can compensate for the interaction without increasing the risk of adverse effects.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Microbiology

Hyperbaric oxygen therapy augments ciprofloxacin effect against Pseudomonas aeruginosa biofilm infected chronic wounds in a mouse model

Anne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, Mette Kolpen, Peter Ostrup Jensen, Henrik Calum, Niels Hoiby, Kim Thomsen, Claus Moser

Summary: Chronic wounds have compromised microcirculation and are often infested with microorganisms in biofilms, hindering antibiotic function. This study investigates whether hyperbaric oxygen therapy (HBOT) can counteract this process.

BIOFILM (2023)

Article Microbiology

Hyperbaric oxygen therapy counteracts Pseudomonas aeruginosa biofilm micro-compartment phenomenon in murine thermal wounds

Anne Sofie Laulund, Franziska Angelika Schwartz, Niels Hoiby, Kim Thomsen, Claus Moser

Summary: The study demonstrates that hyperbaric oxygen therapy (HBOT) can enhance the effectiveness of tobramycin in biofilms and counteract the micro-compartmentalization of biofilm pharmacokinetics through increased available tobramycin and augmented bacterial killing.

BIOFILM (2023)

Article Immunology

Adaptive Immune Response to Mycobacterium abscessus Complex (MABSC) in Cystic Fibrosis and the Implications of Cross-Reactivity

Renan Marrichi Mauch, Peter ostrup Jensen, Tavs Qvist, Mette Kolpen, Claus Moser, Tacjana Pressler, Marcos Tadeu Nolasco da Silva, Niels Hoiby, Copenhagen Study Grp Mycobacterial Infect Cyst Fibrosis

Summary: This study aimed to investigate the adaptive immune response to Mycobacterium abscessus complex (MABSC) and its cross-reactivity with Mycobacterium avium complex (MAC) and Mycobacterium bovis (BCG) in cystic fibrosis (CF) patients and non-CF controls. The results showed a similar immune response pattern in CF patients with MABSC and BCG-vaccinated controls, suggesting cross-reactivity. Importance: 6/10.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

No Data Available